Jonathan Feelemyer, PhD, MS, MPhil
NYU School of Global Public Health - Project Director
Email: jf3880@nyu.edu
Education
PhD, Epidemiology, NYU Grossman School of MedicineMPhil, Epidemiology, NYU Grossman School of Medicine
MS, Epidemiology, University at Albany School of Public Health
BA, Health and Society, University of Rochester
Research Interests
Injecting drug use, epidemiology, HIV, HCV, sexually transmitted diseases, harm reduction, research synthesis BIO
Jonathan Feelemyer is a project director at the NYU School of Global Public Health. His research interests include HIV, hepatitis C, sexually transmitted diseases, injection drug use, and harm reduction for at risk populations. His research is focused on international settings specifically in Southeast Asia and Eastern Europe. He has published numerous publications in academic journals and has presented his work at national and international conferences. He has collaborated with researchers from New York University, Columbia University, the Centers for Disease Control and Prevention, and researchers in Estonia, Vietnam, Russia, France, and other countries. He has worked collaboratively on numerous meta-analysis and systematic review studies, synthesizing research from multiple countries and time periods examining different research topics related to HIV and HCV. He currently works with Dr. Don Des Jarlais on research projects addressing harm reduction, combined prevention, and reductions in HIV and HCV among different at risk populations, with special focus on high prevalence settings worldwide. Projects
Principal Investigator, Comparison of Stigmatization of Monkeypox, Injecting Drug Use, HIV/AIDS, and COVID-19. Completed
Publications
Recent
Hershow RB, Broz D, Faucher L, Feelemyer J, Chapin-Bardales J, Natl HIV Behav Surveillance Study Grp (2025).
HIV testing pre- and post-COVID-19 pandemic among persons who inject drugs – National HIV Behavioral Surveillance, 19 cities, 2018 and 2022
AIDS and Behavior, 29 (4), 1400-1405. doi: 10.1007/s10461-025-04672-4. PMCID: PMC11985261.
HIV testing pre- and post-COVID-19 pandemic among persons who inject drugs – National HIV Behavioral Surveillance, 19 cities, 2018 and 2022
AIDS and Behavior, 29 (4), 1400-1405. doi: 10.1007/s10461-025-04672-4. PMCID: PMC11985261.
Choi J, Feelemyer J, Choe K, Lynch K, McKnight C, Yang LH, Des Jarlais D, Chang VW (2025).
Anti-vaccine attitudes and COVID-19 vaccine status at the end of the U.S. public health emergency
Vaccine, 55, 127003. doi: 10.1016/j.vaccine.2025.127003.
Anti-vaccine attitudes and COVID-19 vaccine status at the end of the U.S. public health emergency
Vaccine, 55, 127003. doi: 10.1016/j.vaccine.2025.127003.
Feelemyer J, Duncan DT, Akhidenor N, Mazumdar M, Irvine NM, Scheidell JD, Brewer RA, Turpin RE, Hucks-Ortiz C, Dyer TV, Cleland CM, Mayer KH, Khan MR (2025).
Police harassment and psychiatric, sexual, and substance use risk among Black sexual minority men and Black transgender women in the HIV Prevention Trials 061 cohort
Journal of Racial and Ethnic Health Disparities, 12 (2), 692-702. doi: 10.1007/s40615-024-01909-1. PMCID: PMC11470103.
Police harassment and psychiatric, sexual, and substance use risk among Black sexual minority men and Black transgender women in the HIV Prevention Trials 061 cohort
Journal of Racial and Ethnic Health Disparities, 12 (2), 692-702. doi: 10.1007/s40615-024-01909-1. PMCID: PMC11470103.
D'Ottavi M, Scialabba I, Huong DT, Giang HT, Khue PM, Vinh VH, Vallo R, Michel L, Rapoud D, Quillet C, Thanh NTT, Bouniol J, Oanh KTH, Feelemyer J, Perre PV, Laureillard D, Des Jarlais D, Nagot N, Moles JP (2025).
High prevalence and incidence of HSV-2 among people who inject drugs in Hai Phong, Vietnam, and risk factors associated with seroconversion
European Journal of Clinical Microbiology and Infectious Diseases [Epub 2025 Feb 22]. doi: 10.1007/s10096-025-05079-8.
High prevalence and incidence of HSV-2 among people who inject drugs in Hai Phong, Vietnam, and risk factors associated with seroconversion
European Journal of Clinical Microbiology and Infectious Diseases [Epub 2025 Feb 22]. doi: 10.1007/s10096-025-05079-8.
Feelemyer J, Braithwaite RS, Zhou Q, Cleland CM, Manandhar-Sasaki P, Wilton L, Ritchie A, Collins LM, Gwadz MV (2024).
Empirical development of a behavioral intervention for African American/Black and Latino persons with unsuppressed HIV viral load levels: An application of the Multiphase Optimization Strategy (MOST) using cost-effectiveness as an optimization objective
AIDS and Behavior, 28 (7), 2378-2390. doi: 10.1007/s10461-024-04335-w. PMCID: PMC11415978.
Empirical development of a behavioral intervention for African American/Black and Latino persons with unsuppressed HIV viral load levels: An application of the Multiphase Optimization Strategy (MOST) using cost-effectiveness as an optimization objective
AIDS and Behavior, 28 (7), 2378-2390. doi: 10.1007/s10461-024-04335-w. PMCID: PMC11415978.
Notable
Retention of participants in medication-assisted programs in low- and middle-income countries: An international systematic review
Addiction, 109 (1), 20-32. doi: 10.1111/add.12303. PMCID: PMC5312702.
Feelemyer J, Des Jarlais DC, Arasteh K, Phillips BW, Hagan H (2014).
Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: An international systematic review
Drug and Alcohol Dependence, 134, 251-258. doi: 10.1016/j.drugalcdep.2013.10.011. PMCID: PMC3880839.
Feelemyer J, Des Jarlais D, Arasteh K, Uuskula A (2015).
Adherence to antiretroviral medications among persons who inject drugs in transitional, low and middle income countries: An international systematic review
AIDS and Behavior, 19 (4), 575-583. doi: 10.1007/s10461-014-0928-3. PMCID: PMC4393761.
Jonathan Feelemyer's ResearchGate Profile